Spruce Biosciences appoints former Zevra Therapeutics CMO Adrian Quartel
read at STAT ↗Neutral
Spruce Biosciences announced the hiring of Adrian Quartel as its new chief medical officer.
Quartel joins Spruce after serving as CMO at Zevra Therapeutics, where he oversaw clinical development.
The appointment reflects Spruce's effort to strengthen its medical leadership amid ongoing drug development initiatives.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗457 words · retrieved Aug 21
comments(0)
5-min edit window · permanent after that